| Name(s) - Formula - CAS Number |
| acyclovir; 2-amino-1,9-dihydro-9-((2-hydroxyethoxy)methyl)-6H-purin-6-one*; acycloguanosine - C8H11N5O3 - 59277-89-3 |
| amiodarone; (2-{4-[(2-butyl-1-benzofuran-3-yl)carbonyl]-2,6-diiodophenoxy}ethyl)diethylamine - C25H29I2NO3 - 1951-25-3 |
| amoxicillin; (2S,5R,6R)-6-{[(2R)-2-amino-2-(4-hydroxyphenyl)-acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid - C16H19N3O5S - 26787-78-0 |
| calcein; fluorexon - C30H26N2O13 - 1461-15-0 |
| cocaine; methyl (1R,2R,3S,5S)-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1] octane-2-carboxylate - C17H21NO4 - 50-36-2 |
| codeine; (5α,6α)-7,8-didehydro-4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol - C18H21NO3 - 76-57-3 |
| cycrimine; 1-cyclopentyl-1-phenyl-3-(piperidin-1-yl)propan-1-ol* - C19H29NO - 77-39-4 |
| EDTA; ethylenediaminetetraacetic acid; 2,2**,2****,2******-(ethane-1,2-diyldinitrilo)tetraacetic acid - C10H16N2O8 - 60-00-4 |
| eperisone; (2RS)-1-(4-ethylphenyl)-2-methyl-3-(1-piperidyl)propan-1-one* - C17H25NO - 56839-43-1 |
| HEPES; 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid - C8H18N2O4S - 7365-45-9 |
| heroin; (5α,6α)-7,8-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol diacetate* - C21H23NO5 - 561-27-3 |
| iloperidone; 1-[4-[3-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1- piperidinyl]propoxy]-3-methoxyphenyl]ethanone*; Fanapta - C24H27FN2O4 - 133454-47-4 |
| imiquimod - C14H16N4 - 99011-02-6 |
| lidocaine; 2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide - C14H22N2O - 137-58-6 |
| lisuride; 1,1-diethyl-3-(7-methyl-4,6,6a,7,8,9-hexahydro-indolo[4,3-fg]quinolin-9-yl)-urea* - C20H26N4O - 18016-80-3 |
| methenamine; hexamine; hexamethylenamine - C6H12N4 - 100-97-0 |
| methyl red - C15H15N3O2 - 493-52-7 |
| morphine; (5α,6α)-7,8-didehydro- 4,5-epoxy-17-methylmorphinan-3,6-diol* - C17H19NO3 - 57-27-2 |
| neutral red; C.I. basic red 5; toluylene red* - C15H17ClN4 - 553-24-2 |
| oxolinic acid; 5-ethyl-8-oxo-5,8-dihydro [1,3] dioxolo [4,5-g] quinoline-7-carboxylic acid* - C13H11NO5 - 14698-29-4 |
| procaine; 2-(diethylamino)ethyl 4-aminobenzoate; novocaine - C13H20N2O2Â - 59-46-1 |
| quinine; (R)-(6-methoxyquinolin-4-yl)((2S,4S,8R)- 8-vinylquinuclidin-2-yl)methanol - C20H24N2O2 - 130-95-0 |
| quinisocaine; 2-(3-butylisoquinolin-1-yl)oxy-N,N-dimethyl-ethanamine* - C17H24N2O - 86-80-6 |
| raloxifene; [6-hydroxy-2-(4-hydroxyphenyl)- benzothiophen-3-yl]- [4-[2-(1-piperidyl)ethoxy]phenyl] -methanone* - C28H27NO4S - 84449-90-1 |
| rilmazafone; 1-[4-chloro-2-(2-chlorobenzoyl)phenyl]-5-[(glycylamino)methyl]-N,N-dimethyl-1H-1,2,4-triazole-3-carboxamide* - C21H20Cl2N6O3 - 99593-25-6 |
| terbinafine; [(2E)-6,6-dimethylhept-2-en-4-yn-1-yl](methyl)(naphthalen-1-ylmethyl)amine* - C21H25N - 91161-71-6 |
| tilisolol; (RS)-4-[3-(tert-butylamino)-2-hydroxypropoxy]-2-methylisoquinolin-1-one* - C17H24N2O3 - 85136-71-6 |
| VX; ethyl {[2-[di(propan-2-yl)amino]ethylsulfanyl} methylphosphinate; S-[2-(diisopropylamino)ethyl]-O-ethyl methylphosphonothioate - C11H26NO2PS - 50782-69-9 |
